Search

A summary of the article "Developing Therapy for Every Kid With Cancer – Summary of a Scientific Session at the 2023 ASCPT Meeting" highlights the challenges and opportunities in developing treatment for children with cancer. The session emphasized the need for a multidisciplinary approach to address the limited understanding of physiological differences, ethical considerations, and small patient populations. The first talk focused on the challenges of treating infants and neonates, who require unique dosing regimens due to their rapidly maturing physiological processes. The second talk discussed racial and ethnic disparities in childhood cancer outcomes, with specific genetic variants and socio-economic factors contributing to worse outcomes for minority children. The final talk addressed roadblocks in clinical trial development and suggested flexible approaches to prioritize scientifically necessary aspects of trials and reduce travel costs for families. The session aimed to stimulate further discussions and collaborations among attendees. [Extracted from the article]